The Prevalence of Acquired Renal Cystic Disease by Ultrasound in Adults of Lahore City

2020 ◽  
pp. 24-28
Author(s):  
OJS Admin
Keyword(s):  
Renal Disease ◽  
Renal Cysts ◽  
Cystic Disease ◽  
Renal Cystic Disease ◽  
Acquired Renal Cystic Disease ◽  
Thin Walled ◽  
Lahore City

Thin-walled, anechoic fluid-filled sacs that are formed in the kidneys are simple renal cysts and those are abnormal ndings. Simple renal cysts are different from the adult polycystic renal disease.

Acquired Renal Cystic Disease in End-Stage Renal Disease: An Autopsy Study of 155 Cases

1989 ◽  
Vol 9 (4) ◽  
pp. 322-328 ◽  
Author(s):  
Lawrence R. Miller ◽  
Oved Soffer ◽  
Victor H. Nassar ◽  
Michael H. Kutner
Keyword(s):  
Renal Disease ◽  
End Stage Renal Disease ◽  
Cystic Disease ◽  
Autopsy Study ◽  
Renal Cystic Disease ◽  
Acquired Renal Cystic Disease ◽  
Stage Renal Disease ◽  
End Stage

Acquired Renal Cystic Disease and Tumor Markers in Chronic Hemodialysis Patients

1997 ◽  
Vol 20 (2) ◽  
pp. 96-100 ◽  
Author(s):  
M. Polenakovic ◽  
A. Sikole ◽  
S. Dzikova ◽  
B. Polenakovic ◽  
S. Gelev
Keyword(s):  
Tumor Markers ◽  
Renal Cysts ◽  
Carbohydrate Antigen ◽  
Ca 125 ◽  
Neoplastic Disease ◽  
Cystic Disease ◽  
Renal Cystic Disease ◽  
Acquired Renal Cystic Disease ◽  
Patient Groups ◽  
Altered Metabolism

Acquired renal cystic disease (ARCD) is a well documented complication of end-stage renal disease, and it has been related to the duration of dialysis therapy. The association of this condition with renal cell adenoma or carcinoma has already been established. There have also been studies on the concentration of some tumor markers in hemodialysis (HD) patients, clinically free from neoplastic disease, where it was concluded that some tumor markers could be elevated, despite the absence of malignant disease, suggesting their altered metabolism i.e. clearance by the hemodialysis membrane. We compared the pre-dialysis serum concentration of several tumor markers in three groups of chronic HD patients, all of whom had been on maintenance HD treatment for more than 5 years. Group 1 consisted of 16 patients without ARCD with a mean HD treatment duration of 97.06 ± 28.25 months. Group 2 consisted of 32 patients with a mean HD treatment of 105.62 ± 24.4 months, who had ARCD with less than 10 renal cysts detected by ultrasonography. Group 3 consisted of 14 patients with a mean HD duration of 109.92 ± 37.72 months, with ARCD and more than 10 renal cysts. Concentration of the following tumor markers was determined by EIA or ELISA methods: carcinoembryonic antigen (CEA), mucin-like carcinoma-associated antigen (MCA), neuron-specific enolase (NSE), carbohydrate antigen 19-9 (CA 19-9), prostatic specific antigen (PSA), carbohydrate antigen 125 (CA 125), alpha fetoprotein (AFP), cytokeratin 19-fragments 21-1 (CYFRA 21-1). The concentration of all the tumor markers was comparable in all three patient groups, with no statistically significant difference between groups. The mean concentrations of MCA, PSA, CA 125 and AFP were within the normal range. CEA and CYFRA 21-1 had mean values in the upper limit of their normal values, while NSE and CA 19-9 were increased by more than twofold in all three patient groups. We concluded that (i) tumor markers should be used with caution when diagnosing neoplastic diseases in chronic HD patients, because of their altered metabolism, and (ii) that in the follow up of ARCD with possible neoplastic alteration, imaging techniques remain dominant diagnostic tools.

scholarly journals Spontaneous Hemorrhage in Acquired Renal Cystic Disease

2010 ◽  
Vol 21 (1) ◽  
pp. 58-62
Author(s):  
Fee-Le Chen ◽  
Yuan-Lung Yang ◽  
Pi-Jen Hong
Keyword(s):  
Cystic Disease ◽  
Renal Cystic Disease ◽  
Spontaneous Hemorrhage ◽  
Acquired Renal Cystic Disease

Miscellaneous urological diseases of the kidney

2013 ◽  
pp. 395-426
Author(s):  
John Reynard ◽  
Simon Brewster ◽  
Suzanne Biers
Keyword(s):  
Vesicoureteric Reflux ◽  
Horseshoe Kidney ◽  
Renal Cysts ◽  
Cystic Disease ◽  
Ectopic Kidney ◽  
Medullary Sponge Kidney ◽  
Renal Cystic Disease ◽  
Calyceal Diverticulum ◽  
Autosomal Dominant Polycystic Kidney ◽  
Urological Diseases

Simple and complex renal cysts 396 Calyceal diverticulum 399 Medullary sponge kidney (MSK) 400 Acquired renal cystic disease (ARCD) 402 Autosomal dominant polycystic kidney disease (ADPKD) 404 Vesicoureteric reflux in adults 408 Pelviureteric junction obstruction in adults 412 Anomalies of renal fusion and ascent: horseshoe kidney, ectopic kidney ...

Renal cell carcinoma in acquired renal cystic disease following renal transplantation

2013 ◽  
Vol 84 (1-2) ◽  
pp. 91-92
Author(s):  
John Samuel Banerji ◽  
Santosh Kumar Singh ◽  
Nitin Sudhakar Kekre
Keyword(s):  
Renal Cell Carcinoma ◽  
Renal Transplantation ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Cystic Disease ◽  
Renal Cystic Disease ◽  
Acquired Renal Cystic Disease

Acquired Renal Cystic Disease and Its Complications in Continuous Ambulatory Peritoneal Dialysis Patients

1992 ◽  
Vol 12 (3) ◽  
pp. 292-297 ◽  
Author(s):  
Isao Ishikawa
Keyword(s):  
Renal Cell Carcinoma ◽  
Peritoneal Dialysis ◽  
Cell Carcinoma ◽  
Continuous Ambulatory Peritoneal Dialysis ◽  
Renal Cell ◽  
Hemodialysis Patients ◽  
Cystic Disease ◽  
Renal Cystic Disease ◽  
Acquired Renal Cystic Disease ◽  
Acquired Cystic Disease

Purpose To determine whether there is any difference in the prevalence of acquired cystic disease and malignancy of the kidney in patients on continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis. Data Identification Relevant studies published from January 1983 to June 1991 were identified by manual search and MEDLINE search. Study Selection We reviewed the studies in which acquired renal cystic disease and/or renal cell carcinoma developed in patients on CAPD. Data Extraction Details of the prevalence of acquired cystic disease and renal malignancy as a complication of acquired cysts in CAPD patients were tabulated with the duration of treatment. Results Acquired cystic disease was observed in 195 of 425CAPD patients(41.1%), which is comparable to the prevalence of 47.1% (520/1103) seen in hemodialysis patients. The overall prevalence of renal cell carcinoma accompanying acquired cystic disease in this series of CAPD patients was 2 of 375 (0.4%), which is comparable to the prevalence of 1.5% (17/1103) in hemodialysis patients. So far, eight other instances of renal cell carcinoma complicating acquired cystic disease in CAPD patients were described as case reports. Retroperitoneal bleeding due to the rupture of acquired cysts has been reported on a few occasions. Conclusion In this review no differences were detected in the prevalence or severity of acquired renal cystic disease in patients treated with CAPD as compared with those on hemodialysis. Therefore, the incidence of complications associated with acquired cysts may also be the same for the two treatment modalities, although reports on such complications are rare.

scholarly journals Cyst infection in acquired renal cystic disease.

BMJ ◽  
1987 ◽  
Vol 295 (6589) ◽  
pp. 25-25 ◽  
Author(s):  
J Bonal ◽  
A Caralps ◽  
R Lauzurica ◽  
A Serra ◽  
R Romero ◽  
...  
Keyword(s):  
Cystic Disease ◽  
Renal Cystic Disease ◽  
Cyst Infection ◽  
Acquired Renal Cystic Disease
Sign in / Sign up

Export Citation Format

Share Document